Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Angle Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5326
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. Angle Biosciences offers software for method creation, data gathering and data analysis. The company’s products are used in simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Angle Biosciences is headquartered in Toronto, Ontario, Canada.

Angle Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
Asset Transactions 14
ANGLE Acquires Assets from Axela 14
Acquisition 15
Axela Mulls Offering Itself For Sale 15
Angle Biosciences Inc – Key Competitors 16
Angle Biosciences Inc – Key Employees 17
Angle Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
ANGLE Acquires Assets from Axela 14
Axela Mulls Offering Itself For Sale 15
Angle Biosciences Inc, Key Competitors 16
Angle Biosciences Inc, Key Employees 17

List of Figures
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tata Steel Group:企業の戦略・SWOT・財務情報
    Tata Steel Group - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SmithGroupJJR:企業の戦略・SWOT・財務情報
    SmithGroupJJR - Strategy, SWOT and Corporate Finance Report Summary SmithGroupJJR - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • IREN SpA (IRE):企業の財務・戦略的SWOT分析
    IREN SpA (IRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • EQT Corporation (EQT):石油・ガス:M&Aディール及び事業提携情報
    Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas, natural gas liquids (NGL), ethane and crude oil. EQT provides gathering, transmissio …
  • TUV Nord AG:企業の戦略的SWOT分析
    TUV Nord AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tobira Therapeutics Inc (TBRA)-医療機器分野:企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bilfinger SE (GBF):電力:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • Israel Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Israel Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SoCore Energy LLC:電力:M&Aディール及び事業提携情報
    Summary SoCore Energy LLC (SoCore Energy), a subsidiary of Edison International is a provider of solar solutions. The company’s services include solar energy development and installations, production monitoring, cost saving energy solutions, financing, procurement, technical and project management, …
  • Tokyu Corp:企業の戦略・SWOT・財務分析
    Tokyu Corp - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • B&G Foods, Inc.:企業のM&A・事業提携・投資動向
    B&G Foods, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's B&G Foods, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Genetic Analysis AS:製品パイプライン分析
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Electricidade de Mocambique EP:電力:M&Aディール及び事業提携情報
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. It produces electricity from hydro and thermal sources. The company has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Berli Jucker Public Co Ltd:企業の戦略・SWOT・財務情報
    Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ams AG (AMS):企業の財務・戦略的SWOT分析
    Summary ams AG (ams) involves in manufacturing and marketing of semiconductor products. The offers various company's which include ultra small ANC speaker driver, environmental sensors, spectral sensing, CMOS imaging sensors, DC-DC boost converters and CT and digital X-ray . It offers power manageme …
  • Mexan Limited:企業の戦略・SWOT・財務分析
    Mexan Limited - Strategy, SWOT and Corporate Finance Report Summary Mexan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆